Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Araceli Naranjo"'
Autor:
Michael C. Jensen, Stephen J. Forman, Massimo D'Apuzzo, Jana Portnow, Julie A. Ressler, James R. Bading, Yubo Zhai, Christine Wright, Jamie Wagner, Renate Starr, Araceli Naranjo, Wen-Chung Chang, Julie R. Ostberg, Lihong Weng, Michael E. Barish, Behnam Badie, Christine E. Brown
Supplementary Figure S4. 18F-Fluorodeoxyglucose ( F-FDG)-CT/PET of subjects UPN031 and UPN033
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69d673474abb794b94ed15a125fb07cc
https://doi.org/10.1158/1078-0432.22457762.v1
https://doi.org/10.1158/1078-0432.22457762.v1
Autor:
Michael C. Jensen, Stephen J. Forman, Massimo D'Apuzzo, Jana Portnow, Julie A. Ressler, James R. Bading, Yubo Zhai, Christine Wright, Jamie Wagner, Renate Starr, Araceli Naranjo, Wen-Chung Chang, Julie R. Ostberg, Lihong Weng, Michael E. Barish, Behnam Badie, Christine E. Brown
Supplementary Figure S1. Catheter position with respect to resection site.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dd70d6df2d1218b30d74ef3452515f5
https://doi.org/10.1158/1078-0432.22457774
https://doi.org/10.1158/1078-0432.22457774
Autor:
Michael C. Jensen, Stephen J. Forman, Massimo D'Apuzzo, Jana Portnow, Julie A. Ressler, James R. Bading, Yubo Zhai, Christine Wright, Jamie Wagner, Renate Starr, Araceli Naranjo, Wen-Chung Chang, Julie R. Ostberg, Lihong Weng, Michael E. Barish, Behnam Badie, Christine E. Brown
Supplementary methods. These are more detailed methods than can be included in the body of the article.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a03b87bb9a78bfdfe3ee2823e26c6cd5
https://doi.org/10.1158/1078-0432.22457753
https://doi.org/10.1158/1078-0432.22457753
Autor:
Michael C. Jensen, Stephen J. Forman, Massimo D'Apuzzo, Jana Portnow, Julie A. Ressler, James R. Bading, Yubo Zhai, Christine Wright, Jamie Wagner, Renate Starr, Araceli Naranjo, Wen-Chung Chang, Julie R. Ostberg, Lihong Weng, Michael E. Barish, Behnam Badie, Christine E. Brown
Supplementary Figure S5. T cell detection in tumor tissue from UPN031.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03642da541194c78c6fc68d25f95ff89
https://doi.org/10.1158/1078-0432.22457759.v1
https://doi.org/10.1158/1078-0432.22457759.v1
Autor:
Michael C. Jensen, Stephen J. Forman, Massimo D'Apuzzo, Jana Portnow, Julie A. Ressler, James R. Bading, Yubo Zhai, Christine Wright, Jamie Wagner, Renate Starr, Araceli Naranjo, Wen-Chung Chang, Julie R. Ostberg, Lihong Weng, Michael E. Barish, Behnam Badie, Christine E. Brown
Supplementary Figure S2. Consort flow diagram.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6de75c99cf95b5eec116a2eb70e5538e
https://doi.org/10.1158/1078-0432.22457771.v1
https://doi.org/10.1158/1078-0432.22457771.v1
Autor:
Michael C. Jensen, Stephen J. Forman, Massimo D'Apuzzo, Jana Portnow, Julie A. Ressler, James R. Bading, Yubo Zhai, Christine Wright, Jamie Wagner, Renate Starr, Araceli Naranjo, Wen-Chung Chang, Julie R. Ostberg, Lihong Weng, Michael E. Barish, Behnam Badie, Christine E. Brown
Supplementary Tables S1-3. Table S1. T cell Product Release Criteria. Table S2. Manufacturing Feasibility. Table S3. Characteristics of Patients Who Received Study Treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c9facdbfd4046390adb39d3f97dbea8
https://doi.org/10.1158/1078-0432.22457756
https://doi.org/10.1158/1078-0432.22457756
Autor:
Michael C. Jensen, Stephen J. Forman, Massimo D'Apuzzo, Jana Portnow, Julie A. Ressler, James R. Bading, Yubo Zhai, Christine Wright, Jamie Wagner, Renate Starr, Araceli Naranjo, Wen-Chung Chang, Julie R. Ostberg, Lihong Weng, Michael E. Barish, Behnam Badie, Christine E. Brown
Supplementary Figure S3. Treatment regimens for each patient, with relapse designated day 0.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02d15163493177928bc3594e26a57e7d
https://doi.org/10.1158/1078-0432.22457765.v1
https://doi.org/10.1158/1078-0432.22457765.v1
Autor:
Michael C. Jensen, Stephen J. Forman, Massimo D'Apuzzo, Jana Portnow, Julie A. Ressler, James R. Bading, Yubo Zhai, Christine Wright, Jamie Wagner, Renate Starr, Araceli Naranjo, Wen-Chung Chang, Julie R. Ostberg, Lihong Weng, Michael E. Barish, Behnam Badie, Christine E. Brown
Purpose: A first-in-human pilot safety and feasibility trial evaluating chimeric antigen receptor (CAR)–engineered, autologous primary human CD8+ cytotoxic T lymphocytes (CTL) targeting IL13Rα2 for the treatment of recurrent glioblastoma (GBM).Exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25abbb9db60c246c8d4457830fb35f5d
https://doi.org/10.1158/1078-0432.c.6523685
https://doi.org/10.1158/1078-0432.c.6523685
Autor:
Michael Barish, Lihong Weng, Dina Awabdeh, Blake Brewster, Massimo D’Apuzzo, Yubo Zhai, Alfonso Brito, Brenda Chang, Annie Sarkissian, Renate Starr, Wen-Chung Chang, Brenda Aguilar, Araceli Naranjo, Suzette Blanchard, Russell Rockne, Behnam Badie, Vanessa Jonsson, Stephen Forman, Christine Brown
Publikováno v:
Poster Presentations.
Background Glioblastoma (GBM) remains an almost universally fatal brain tumor. While CAR T cell immunotherapy has shown promising clinical efficacy, therapeutic failure may reflect our incomplete understanding of target antigen expression. We previou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b027149d9070e40fd4d7ed39b7412665
https://doi.org/10.1136/lba2019.9
https://doi.org/10.1136/lba2019.9
Autor:
Xiuli Wang, Nikita Gidwaney, Adam Norris, M. Suzette Blanchard, Wen-Chung Chang, Michael C. Jensen, Samer K. Khaled, Tanya Siddiqi, Laurence J.N. Cooper, Sandra H. Thomas, Michelle Mott, Araceli Naranjo, Christine E. Brown, Stephen J. Forman, Jamie Wagner, Leslie Popplewell, Ching Lam W Wong, Brenda Chang, Stanley R. Riddell, Lihua E. Budde, Ryan Urak, Jingying Xu
Publikováno v:
Blood. 127:2980-2990
Myeloablative autologous hematopoietic stem cell transplantation (HSCT) is a mainstay of therapy for relapsed intermediate-grade B-cell non-Hodgkin lymphoma (NHL); however, relapse rates are high. In phase 1 studies designed to improve long-term remi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::329746af5d8c52f5b63d4bc211e477e9
https://doi.org/10.1182/blood-2015-12-686725
https://doi.org/10.1182/blood-2015-12-686725